Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0152536007
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Approved | 02537621 | ANGITA PHARMA INC. | AG-LISDEXAMFETAMINE | Human | Yes | Schedule G (CDSA I) | 1 | LISDEXAMFETAMINE DIMESYLATE | 70 MG |
Approved | 02494167 | APOTEX INC | APO-LISDEXAMFETAMINE | Human | Yes | Schedule G (CDSA I) | 1 | LISDEXAMFETAMINE DIMESYLATE | 70 MG |
Approved | 02546728 | APOTEX INC | APO-LISDEXAMFETAMINE CAPSULES | Human | Yes | Schedule G (CDSA I) | 1 | LISDEXAMFETAMINE DIMESYLATE | 70 MG |
Approved | 02535181 | JAMP PHARMA CORPORATION | JAMP LISDEXAMFETAMINE | Human | Yes | Schedule G (CDSA I) | 1 | LISDEXAMFETAMINE DIMESYLATE | 70 MG |
Approved | 02547104 | PRO DOC LIMITEE | PRO-LISDEXAMFETAMINE | Human | Yes | Schedule G (CDSA I) | 1 | LISDEXAMFETAMINE DIMESYLATE | 70 MG |
Marketed | 02546302 | SANDOZ CANADA INCORPORATED | SANDOZ LISDEXAMFETAMINE CAPSULES | Human | Yes | Schedule G (CDSA I) | 1 | LISDEXAMFETAMINE DIMESYLATE | 70 MG |
Marketed | 02545942 | TEVA CANADA LIMITED | TEVA-LISDEXAMFETAMINE | Human | Yes | Schedule G (CDSA I) | 1 | LISDEXAMFETAMINE DIMESYLATE | 70 MG |
Marketed | 02458071 | TAKEDA CANADA INC | VYVANSE | Human | Yes | Schedule G (CDSA I) | 1 | LISDEXAMFETAMINE DIMESYLATE | 70 MG |
Application information
Related information
Contact us
Version 4.0.3